{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:01:24Z","timestamp":1794574884374,"version":"4.9.1"},"reference-count":155,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010376","name":"American Association of Clinical Endocrinologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010376","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.eprac.2025.02.001","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T07:42:20Z","timestamp":1744702940000},"page":"403-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["American Association of Clinical Endocrinology Consensus Statement on Management of Multiple Endocrine Neoplasia Type 1"],"prefix":"10.1016","volume":"31","author":[{"given":"Jaydira","family":"Del Rivero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin P.","family":"Annes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Jasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle D.","family":"Lundholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Silverstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanaz M.","family":"Vaghaiwalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Wermers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eprac.2025.02.001_bib1","first-page":"176","article-title":"Familial syndromes associated with neuroendocrine tumours","volume":"19","author":"Gut","year":"2015","journal-title":"Contemp Oncol (Pozn)"},{"issue":"12","key":"10.1016\/j.eprac.2025.02.001_bib2","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2025.02.001_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","article-title":"Clinical aspects of multiple endocrine neoplasia type 1","volume":"17","author":"Al-Salameh","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00268-009-0290-1","article-title":"Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients","volume":"34","author":"Goudet","year":"2010","journal-title":"World J Surg"},{"issue":"9","key":"10.1016\/j.eprac.2025.02.001_bib5","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2025.02.001_bib6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ng0897-375","article-title":"Somatic mutation of the MEN1 gene in parathyroid tumours","volume":"16","author":"Heppner","year":"1997","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.eprac.2025.02.001_bib7","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J\u00a0Bone Miner Res"},{"issue":"5","key":"10.1016\/j.eprac.2025.02.001_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.eprac.2022.02.010","article-title":"The importance of periodical screening for primary hyperparathyroidism in a pituitary tumor cohort in searching patients with MEN1 and its genetic profile","volume":"28","author":"Damianse","year":"2022","journal-title":"Endocr Pract"},{"issue":"9","key":"10.1016\/j.eprac.2025.02.001_bib9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/qjmed\/89.9.653","article-title":"Clinical studies of multiple endocrine neoplasia type 1 (MEN1)","volume":"89","author":"Trump","year":"1996","journal-title":"QJM"},{"issue":"8","key":"10.1016\/j.eprac.2025.02.001_bib10","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.090304","article-title":"Sporadic and MEN1-related\u00a0primary hyperparathyroidism: differences in clinical expression and severity","volume":"24","author":"Eller-Vainicher","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"issue":"10","key":"10.1016\/j.eprac.2025.02.001_bib11","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.md.0000112297.72510.32","article-title":"Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature","volume":"83","author":"Gibril","year":"2004","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.eprac.2025.02.001_bib13","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s00268-012-1451-1","article-title":"Preoperative localizing studies for initial parathyroidectomy in MEN1 syndrome: is there any benefit?","volume":"36","author":"Nilubol","year":"2012","journal-title":"World J Surg"},{"issue":"11","key":"10.1016\/j.eprac.2025.02.001_bib14","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/jbmr.4689","article-title":"Surgical aspects of primary hyperparathyroidism","volume":"37","author":"Perrier","year":"2022","journal-title":"J\u00a0Bone Miner Res"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.surg.2020.08.021","article-title":"Optimal extent of initial parathyroid resection in patients with multiple endocrine neoplasia syndrome type 1: a meta-analysis","volume":"169","author":"Nastos","year":"2021","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.eprac.2025.02.001_bib16","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0039-6060(03)00406-9","article-title":"Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1","volume":"134","author":"Elaraj","year":"2003","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.eprac.2025.02.001_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2302892","article-title":"Health consequences of thymus removal in adults","volume":"389","author":"Kooshesh","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.eprac.2025.02.001_bib18","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00268-011-1068-9","article-title":"The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review","volume":"35","author":"Schreinemakers","year":"2011","journal-title":"World J Surg"},{"issue":"8","key":"10.1016\/j.eprac.2025.02.001_bib19","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s00268-013-2054-1","article-title":"Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy","volume":"37","author":"Nilubol","year":"2013","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.eprac.2025.02.001_bib20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2265.2009.03672.x","article-title":"Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy","volume":"72","author":"Coutinho","year":"2010","journal-title":"Clin Endocrinol"},{"issue":"10","key":"10.1016\/j.eprac.2025.02.001_bib21","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1210\/jc.2019-00705","article-title":"Persistently elevated PTH after parathyroidectomy at one year: experience in a tertiary referral center","volume":"104","author":"Caldwell","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.surg.2020.05.049","article-title":"Early biochemical response to parathyroidectomy for primary hyperparathyroidism and its predictive value for recurrent hypercalcemia and recurrent primary hyperparathyroidism","volume":"169","author":"Ryder","year":"2021","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.eprac.2025.02.001_bib23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12020-015-0696-5","article-title":"Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to multiple endocrine neoplasia syndrome type 1 (MEN1)","volume":"52","author":"Giusti","year":"2016","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib24","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1210\/jc.2014-3255","article-title":"Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1","volume":"100","author":"Singh","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2025.02.001_bib25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2265.2007.02934.x","article-title":"Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers","volume":"67","author":"Machens","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.eprac.2025.02.001_bib26","first-page":"1132","article-title":"Pituitary adenomas in the setting\u00a0of multiple endocrine neoplasia type 1: a single-institution experience","volume":"134","author":"Cohen-Cohen","year":"2020","journal-title":"J\u00a0Neurosurg"},{"issue":"6","key":"10.1016\/j.eprac.2025.02.001_bib27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1530\/EJE-21-0630","article-title":"Pituitary adenoma in patients with multiple endocrine neoplasia type 1: a cohort study","volume":"185","author":"Le Bras","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2025.02.001_bib28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2011.04227.x","article-title":"Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database","volume":"76","author":"Sakurai","year":"2012","journal-title":"Clin Endocrinol"},{"issue":"12","key":"10.1016\/j.eprac.2025.02.001_bib29","doi-asserted-by":"crossref","first-page":"e1532","DOI":"10.1210\/clinem\/dgad387","article-title":"Traits of patients with pituitary tumors in multiple endocrine neoplasia type 1 and comparing different mutation status","volume":"108","author":"Lin","year":"2023","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11102-019-00939-x","article-title":"Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China","volume":"22","author":"Wu","year":"2019","journal-title":"Pituitary"},{"issue":"12","key":"10.1016\/j.eprac.2025.02.001_bib31","first-page":"4776","article-title":"Pituitary macroadenoma in\u00a0a 5-year-old: an early expression of multiple endocrine neoplasia type 1","volume":"85","author":"Stratakis","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2025.02.001_bib32","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","article-title":"Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients","volume":"32","author":"Trouillas","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study","volume":"87","author":"Verg\u00e8s","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2025.02.001_bib34","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1210\/JC.2015-2015","article-title":"Long-term natural course of pituitary tumors in patients with MEN1: results from the DutchMEN1 Study Group (DMSG)","volume":"100","author":"de Laat","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2265.2010.03896.x","article-title":"Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects","volume":"74","author":"Colao","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/EJE-10-0744","article-title":"Limited utility of oral glucose tolerance test in biochemically active acromegaly","volume":"164","author":"Ribeiro-Oliveira","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"16","key":"10.1016\/j.eprac.2025.02.001_bib37","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/jama.2023.5444","article-title":"Diagnosis and management of pituitary adenomas: a review","volume":"329","author":"Tritos","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.eprac.2025.02.001_bib38","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s12020-015-0702-y","article-title":"Role of (68)Ga-DOTATATE PET\/CT in patients with multiple endocrine neoplasia type 1 (MEN1)","volume":"52","author":"Lastoria","year":"2016","journal-title":"Endocrine"},{"issue":"8","key":"10.1016\/j.eprac.2025.02.001_bib39","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1007\/s00268-017-3992-9","article-title":"Is routine screening of young asymptomatic MEN1 patients necessary?","volume":"41","author":"Manoharan","year":"2017","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11102-013-0462-8","article-title":"Frequency of multiple endocrine neoplasia type 1 in a group of patients with pituitary adenoma: genetic study and familial screening","volume":"17","author":"Nunes","year":"2014","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eprac.2022.10.004","article-title":"Pituitary incidentalomas: best practices and looking ahead","volume":"29","author":"Giraldi","year":"2023","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.eprac.2025.02.001_bib42","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1210\/jc.2010-1048","article-title":"Pituitary incidentaloma: an endocrine society clinical practice guideline","volume":"96","author":"Freda","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2025.02.001_bib43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ando.2015.04.004","article-title":"Management of nonfunctioning pituitary incidentaloma","volume":"76","author":"Galland","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.eprac.2025.02.001_bib45","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society International Consensus Statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2025.02.001_bib46","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1210\/jc.2011-0251","article-title":"Radiation therapy in the management of pituitary adenomas","volume":"96","author":"Loeffler","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2025.02.001_bib47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000370065","article-title":"Management of electrolyte and fluid disorders after brain surgery for pituitary\/suprasellar tumours","volume":"83","author":"Edate","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.eprac.2025.02.001_bib48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/B978-0-444-59602-4.00012-5","article-title":"Nonfunctioning pituitary tumors","volume":"124","author":"Molitch","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"10.1016\/j.eprac.2025.02.001_bib49","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/jc.2010-1054","article-title":"Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis","volume":"96","author":"Fern\u00e1ndez-Balsells","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib50","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11102-017-0856-0","article-title":"Management of nonfunctioning pituitary adenomas (NFAs): observation","volume":"21","author":"Huang","year":"2018","journal-title":"Pituitary"},{"issue":"7","key":"10.1016\/j.eprac.2025.02.001_bib51","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1159\/000511791","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and the pancreas - diagnosis and treatment of functioning and non-functioning pancreatic and duodenal neuroendocrine neoplasia within the MEN1 syndrome - an international consensus statement","volume":"111","author":"Niederle","year":"2021","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib52","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12916-016-0708-1","article-title":"MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients","volume":"14","author":"de Laat","year":"2016","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.eprac.2025.02.001_bib53","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1210\/jc.2018-01170","article-title":"UMD-MEN1 database: an overview of the 370 MEN1 variants present in 1676 patients from the French population","volume":"104","author":"Romanet","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.eprac.2025.02.001_bib54","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1210\/jcem.86.11.8011","article-title":"Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form","volume":"86","author":"Gibril","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2025.02.001_bib55","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/jso.25667","article-title":"Prognostic factors and survival in MEN1 patients with gastrinomas: results from the DutchMEN study group (DMSG)","volume":"120","author":"van Beek","year":"2019","journal-title":"J\u00a0Surg Oncol"},{"issue":"6","key":"10.1016\/j.eprac.2025.02.001_bib56","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/SLA.0000000000003162","article-title":"Metastatic potential and survival of duodenal and pancreatic tumors in multiple endocrine neoplasia type 1: a GTE and AFCE Cohort Study (Groupe d'\u00e9tude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne)","volume":"272","author":"Vinault","year":"2020","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.eprac.2025.02.001_bib57","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4158\/EP161639.OR","article-title":"Prognostic factors for survival of MEN1 patients with duodenopancreatic tumors metastatic to the liver: results from the DMSG","volume":"23","author":"Conemans","year":"2017","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.eprac.2025.02.001_bib58","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MPA.0000000000000825","article-title":"Treatment of pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: some clarity but continued controversy","volume":"46","author":"Jensen","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.eprac.2025.02.001_bib59","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fendo.2019.00339","article-title":"Multiple endocrine neoplasia type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis","volume":"10","author":"Kamilaris","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib60","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","article-title":"Multiple endocrine neoplasia type 1: latest insights","volume":"42","author":"Brandi","year":"2021","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.eprac.2025.02.001_bib61","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.sla.0000143252.02142.3e","article-title":"Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome","volume":"240","author":"Norton","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.eprac.2025.02.001_bib62","series-title":"Endotext","article-title":"Multiple endocrine neoplasia type 1","author":"Pieterman","year":"2000"},{"issue":"12","key":"10.1016\/j.eprac.2025.02.001_bib63","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s00268-004-7609-8","article-title":"Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors","volume":"28","author":"Dralle","year":"2004","journal-title":"World J Surg"},{"issue":"5","key":"10.1016\/j.eprac.2025.02.001_bib64","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/01.pas.0000194044.01104.25","article-title":"Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome","volume":"30","author":"Anlauf","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib65","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.beem.2006.12.004","article-title":"Surgery on neuroendocrine tumours","volume":"21","author":"Akerstr\u00f6m","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib66","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.eprac.2025.02.001_bib67","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.coemr.2021.04.007","article-title":"Functioning and nonfunctioning pNENs","volume":"18","author":"Daskalakis","year":"2021","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"9","key":"10.1016\/j.eprac.2025.02.001_bib68","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1210\/js.2018-00087","article-title":"Diagnosing nonfunctional pancreatic NETs in MEN1: the evidence base","volume":"2","author":"van Treijen","year":"2018","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.eprac.2025.02.001_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.654975","article-title":"The impact of (68)Gallium DOTA PET\/CT in managing patients with sporadic and familial pancreatic neuroendocrine tumours","volume":"12","author":"Cuthbertson","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.eprac.2025.02.001_bib70","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2217\/ije-2017-0018","article-title":"Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing","volume":"4","author":"Metz","year":"2017","journal-title":"Int J Endocr Oncol"},{"issue":"3","key":"10.1016\/j.eprac.2025.02.001_bib156","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000531766","article-title":"International Guidelines for the Diagnosis and Management of Hyperinsulinism","volume":"97","author":"De Leon","year":"2024","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib71","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JME-20-0020","article-title":"c-MET inhibition: novel treatment for sporadic and MEN1-associated GEP NETs","volume":"65","author":"Lee","year":"2020","journal-title":"J\u00a0Mol Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2025.02.001_bib72","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.pan.2017.07.196","article-title":"Prognostic value of WHO grade in pancreatic neuro-endocrine tumors in multiple endocrine neoplasia type 1: results from the DutchMEN1 Study Group","volume":"17","author":"Conemans","year":"2017","journal-title":"Pancreatology"},{"issue":"21","key":"10.1016\/j.eprac.2025.02.001_bib155","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.3390\/cancers14215248","article-title":"Treatment sequencing strategies in advanced neuroendocrine tumors: a review","volume":"14","author":"Chauhan","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.eprac.2025.02.001_bib73","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00423-011-0828-1","article-title":"Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1","volume":"396","author":"Lopez","year":"2011","journal-title":"Langenbecks Arch Surg"},{"issue":"6","key":"10.1016\/j.eprac.2025.02.001_bib74","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1530\/ERC-19-0372","article-title":"Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature","volume":"27","author":"Sadowski","year":"2020","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib75","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/SLA.0000000000002191","article-title":"Long-term follow-up of MEN1 patients who do not have initial surgery for small \u22642 cm nonfunctioning pancreatic neuroendocrine tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines","volume":"268","author":"Triponez","year":"2018","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib76","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.sla.0000197715.96762.68","article-title":"Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas","volume":"243","author":"Triponez","year":"2006","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.eprac.2025.02.001_bib77","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00268-005-0354-9","article-title":"Is surgery beneficial for MEN1 patients with small (< or\u00a0= 2 cm), nonfunctioning pancreaticoduodenal endocrine\u00a0tumor? An analysis of 65 patients from the GTE","volume":"30","author":"Triponez","year":"2006","journal-title":"World J Surg"},{"issue":"10","key":"10.1016\/j.eprac.2025.02.001_bib78","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1210\/jc.2017-00372","article-title":"Long-term natural course of small nonfunctional pancreatic neuroendocrine tumors in MEN1-results from the Dutch MEN1 Study Group","volume":"102","author":"Pieterman","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib79","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/SLA.0b013e3182536339","article-title":"Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1","volume":"257","author":"Lopez","year":"2013","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib80","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12020-017-1234-4","article-title":"Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database","volume":"58","author":"Giusti","year":"2017","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib81","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12020-020-02217-4","article-title":"Long-term outcomes in MEN-1 patients with\u00a0pancreatic neuroendocrine neoplasms: an Israeli specialist center experience","volume":"68","author":"Oleinikov","year":"2020","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.eprac.2025.02.001_bib82","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.surg.2020.09.037","article-title":"Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: functionality matters","volume":"169","author":"van Beek","year":"2021","journal-title":"Surgery"},{"issue":"Suppl 3","key":"10.1016\/j.eprac.2025.02.001_bib83","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4158\/EP10376.RA","article-title":"Pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: review of literature","volume":"17","author":"Tonelli","year":"2011","journal-title":"Endocr Pract"},{"issue":"8","key":"10.1016\/j.eprac.2025.02.001_bib84","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.3390\/ijms22084041","article-title":"Pancreatic neuroendocrine neoplasms in multiple endocrine neoplasia type 1","volume":"22","author":"Marini","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.eprac.2025.02.001_bib85","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1210\/jc.2014-1560","article-title":"Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients","volume":"99","author":"de Laat","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2025.02.001_bib86","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12020-022-03099-4","article-title":"Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1","volume":"77","author":"Yliaska","year":"2022","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib87","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2265.2012.04467.x","article-title":"Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptions","volume":"78","author":"Sakurai","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.eprac.2025.02.001_bib88","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/cen.13480","article-title":"Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: a single-centre study, systematic review and meta-analysis","volume":"87","author":"Ye","year":"2017","journal-title":"Clin\u00a0Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib89","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-23-0162","article-title":"Beyond the three P\u2019s: adrenal involvement in MEN1","volume":"31","author":"Clemente-Gutierrez","year":"2024","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"10.1016\/j.eprac.2025.02.001_bib90","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00268-002-6492-4","article-title":"Adrenal involvement in multiple endocrine neoplasia type 1","volume":"26","author":"Langer","year":"2002","journal-title":"World J Surg"},{"issue":"5","key":"10.1016\/j.eprac.2025.02.001_bib91","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/EJE-07-0635","article-title":"Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study","volume":"158","author":"Schaefer","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib92","first-page":"76","article-title":"Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1","volume":"75","author":"Skogseid","year":"1992","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib93","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-11-0679","article-title":"Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database","volume":"166","author":"Gatta-Cherifi","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"13","key":"10.1016\/j.eprac.2025.02.001_bib94","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1158\/1078-0432.CCR-23-3308","article-title":"A\u00a0cohort study of CNS tumors in multiple endocrine neoplasia type 1","volume":"30","author":"Graillon","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.eprac.2025.02.001_bib95","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1007\/s13311-022-01277-w","article-title":"Nervous system (NS) tumors in cancer predisposition syndromes","volume":"19","author":"Patil","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.eprac.2025.02.001_bib97","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/EJE-17-1056","article-title":"Diagnostic accuracy of computed tomography to identify adenomas among adrenal incidentalomas in an endocrinological population","volume":"178","author":"Marty","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib98","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1530\/EJE-21-0650","article-title":"Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses","volume":"186","author":"Schloetelburg","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2025.02.001_bib99","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4158\/EP.ep.14.3.269","article-title":"Adrenal incidentalomas: diagnostic evaluation and long-term follow-up","volume":"14","author":"Vilar","year":"2008","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib100","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.eprac.2025.02.001_bib101","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1007\/s00330-015-3787-z","article-title":"FDG-PET\/CT and FLT-PET\/CT for differentiating between lipid-poor benign and malignant adrenal tumours","volume":"25","author":"Nakajo","year":"2015","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.eprac.2025.02.001_bib102","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1210\/clinem\/dgab005","article-title":"18F-FDG-PET\/CT Evaluation of indeterminate adrenal masses in noncancer patients","volume":"106","author":"He","year":"2021","journal-title":"J\u00a0Clin Endocrinol\u00a0Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib103","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/cen.14338","article-title":"Risk stratification of adrenal masses by [(18) F]FDG PET\/CT: changing tactics","volume":"94","author":"Salgues","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.1016\/j.eprac.2025.02.001_bib104","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1210\/jc.2017-00254","article-title":"Performance of 18F-FDG PET\/CT in the characterization of adrenal masses in noncancer patients: a prospective study","volume":"102","author":"Guerin","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2025.02.001_bib105","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/cen.13117","article-title":"Procedural and clinical outcomes of percutaneous adrenal biopsy in a high-risk population for adrenal malignancy","volume":"85","author":"Delivanis","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"10.1016\/j.eprac.2025.02.001_bib106","first-page":"986","article-title":"Fine-needle aspiration of adrenal lesions: a 20-year single institution experience with comparison of\u00a0percutaneous and endoscopic ultrasound guided approaches","volume":"47","author":"Novotny","year":"2019","journal-title":"Diagn\u00a0Cytopathol"},{"issue":"9","key":"10.1016\/j.eprac.2025.02.001_bib107","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S2213-8587(20)30218-7","article-title":"Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study","volume":"8","author":"Bancos","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.eprac.2025.02.001_bib108","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1210\/jc.2011-1565","article-title":"Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors","volume":"96","author":"Arlt","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2025.02.001_bib109","doi-asserted-by":"crossref","first-page":"e1181","DOI":"10.1210\/clinem\/dgab751","article-title":"Plasma steroid profiling in patients with adrenal incidentaloma","volume":"107","author":"Berke","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2025.02.001_bib110","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1210\/jc.2016-3690","article-title":"MEN1-dependent breast cancer: indication for early screening? Results from the Dutch MEN1 Study Group","volume":"102","author":"van Leeuwaarde","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2025.02.001_bib111","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMc1406028","article-title":"Breast-cancer predisposition in multiple endocrine neoplasia type 1","volume":"371","author":"Dreijerink","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.eprac.2025.02.001_bib112","first-page":"468","article-title":"Multiple endocrine neoplasia type 1 and breast cancer. An association to consider","volume":"65","author":"Herranz-Antol\u00edn","year":"2018","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib113","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12020-020-02476-1","article-title":"Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study","volume":"71","author":"Falcetta","year":"2021","journal-title":"Endocrine"},{"issue":"23","key":"10.1016\/j.eprac.2025.02.001_bib114","first-page":"5509","article-title":"Predictors of tumour growth and autonomous cortisol secretion development during follow-up in non-functioning adrenal incidentalomas","volume":"10","author":"Araujo-Castro","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"5","key":"10.1016\/j.eprac.2025.02.001_bib115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/a-1079-4915","article-title":"Clinical characteristics and follow-up results of adrenal incidentaloma","volume":"129","author":"Yilmaz","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.eprac.2025.02.001_bib116","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12902-015-0001-x","article-title":"Limited value of long-term biochemical follow-up in patients with adrenal incidentalomas-a retrospective cohort study","volume":"15","author":"Yeomans","year":"2015","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"10.1016\/j.eprac.2025.02.001_bib117","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-09-0957","article-title":"Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas","volume":"162","author":"Giordano","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2025.02.001_bib118","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2265.2008.03492.x","article-title":"Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study","volume":"70","author":"Vassilatou","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.eprac.2025.02.001_bib119","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.surg.2008.08.031","article-title":"The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidism","volume":"144","author":"Powell","year":"2008","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1530\/EC-17-0271","article-title":"Nationwide multicenter study on the management of pulmonary neuroendocrine (carcinoid) tumors","volume":"7","author":"Sadowski","year":"2018","journal-title":"Endocr Connect"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib121","doi-asserted-by":"crossref","first-page":"e1014","DOI":"10.1210\/clinem\/dgaa800","article-title":"The management of neuroendocrine tumors of the lung in MEN1: results from the Dutch MEN1 Study Group","volume":"106","author":"van den Broek","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2025.02.001_bib122","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jamasurg.2022.3544","article-title":"American Association of Endocrine Surgeons Guidelines for adrenalectomy: executive summary","volume":"157","author":"Yip","year":"2022","journal-title":"JAMA Surg"},{"issue":"11","key":"10.1016\/j.eprac.2025.02.001_bib123","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1210\/jc.2004-0218","article-title":"Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1","volume":"89","author":"Asgharian","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.eprac.2025.02.001_bib124","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5070\/D38VZ279QG","article-title":"Angiofibromas in multiple endocrine neoplasia type 1","volume":"18","author":"Vashi","year":"2012","journal-title":"Dermatol Online J"},{"issue":"7","key":"10.1016\/j.eprac.2025.02.001_bib125","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1468-3083.2008.02578.x","article-title":"Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1","volume":"22","author":"Vidal","year":"2008","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib126","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ando.2023.09.003","volume":"85","author":"Goudet","year":"2024","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.eprac.2025.02.001_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1191040","article-title":"Cutaneous lesions and other non-endocrine\u00a0manifestations of multiple endocrine neoplasia type 1 syndrome","volume":"14","author":"Pierotti","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.eprac.2025.02.001_bib128","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/jc.2014-3659","article-title":"MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'\u00e9tude des Tumeurs Endocrines","volume":"100","author":"Goudet","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.2005.02190.x","article-title":"Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing","volume":"62","author":"Ellard","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/j.eprac.2025.02.001_bib130","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.2007-0476","article-title":"Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases","volume":"92","author":"Tham","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7643","key":"10.1016\/j.eprac.2025.02.001_bib131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib132","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10689-020-00222-0","article-title":"Genetic evaluation of patients and families with concern for hereditary endocrine tumor syndromes","volume":"21","author":"Anderson","year":"2022","journal-title":"Fam Cancer"},{"issue":"4","key":"10.1016\/j.eprac.2025.02.001_bib133","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1590\/S1807-59322007000400014","article-title":"The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1","volume":"62","author":"Louren\u00e7o","year":"2007","journal-title":"Clinics (Sao Paulo)"},{"issue":"5","key":"10.1016\/j.eprac.2025.02.001_bib134","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/01.sla.0000124383.98416.8d","article-title":"Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1)","volume":"239","author":"Lairmore","year":"2004","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.eprac.2025.02.001_bib135","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1055\/s-0031-1286324","article-title":"Clinical and prognostic implications of the genetic diagnosis of hereditary NET syndromes in asymptomatic patients","volume":"43","author":"Ramundo","year":"2011","journal-title":"Horm Metab Res"},{"issue":"4","key":"10.1016\/j.eprac.2025.02.001_bib136","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2265.2008.03324.x","article-title":"Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome","volume":"70","author":"Pieterman","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.eprac.2025.02.001_bib137","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1210\/jc.2015-3766","article-title":"Impact of delay in diagnosis in outcomes in MEN1: results from the Dutch MEN1 Study Group","volume":"101","author":"van Leeuwaarde","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib138","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.GIM.0000153663.62300.F8","article-title":"Clinical testing for multiple\u00a0endocrine\u00a0neoplasia type 1 in a DNA diagnostic laboratory","volume":"7","author":"Klein","year":"2005","journal-title":"Genet Med"},{"issue":"10","key":"10.1016\/j.eprac.2025.02.001_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186485","article-title":"Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features","volume":"12","author":"Pardi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.eprac.2025.02.001_bib140","article-title":"Genetic testing for familial hyperparathyroidism: clinical-genetic profile in a Mediterranean cohort","volume":"14","author":"Mazarico-Altisent","year":"2023","journal-title":"Front\u00a0Endocrinol (Lausanne)"},{"issue":"5-6","key":"10.1016\/j.eprac.2025.02.001_bib141","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s12672-020-00394-2","article-title":"Outcome of clinical genetic testing in patients with features suggestive for hereditary predisposition to PTH-mediated hypercalcemia","volume":"11","author":"Khairi","year":"2020","journal-title":"Horm Cancer"},{"issue":"5","key":"10.1016\/j.eprac.2025.02.001_bib142","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"GCM2-activating mutations in familial isolated hyperparathyroidism","volume":"99","author":"Guan","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.eprac.2025.02.001_bib143","doi-asserted-by":"crossref","first-page":"e2271","DOI":"10.1210\/clinem\/dgaa142","article-title":"Clinical MEN-1 among a large cohort of patients with acromegaly","volume":"105","author":"Nachtigall","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2025.02.001_bib144","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","article-title":"Multiple endocrine tumors associated with germline MAX mutations: multiple endocrine neoplasia type 5?","volume":"106","author":"Seabrook","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13023-018-0938-8","article-title":"Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients","volume":"13","author":"Marini","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib146","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1086\/301953","article-title":"Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders","volume":"63","author":"Giraud","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib147","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.surg.2017.04.044","article-title":"Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: a 23-year experience at a single institution","volume":"163","author":"Christakis","year":"2018","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.eprac.2025.02.001_bib148","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/eje.0.1450155","article-title":"Familial isolated\u00a0primary hyperparathyroidism--a multiple endocrine neoplasia type 1 variant?","volume":"145","author":"Miedlich","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib149","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ncpendmet0718","article-title":"Familial isolated primary hyperparathyroidism caused by mutations of the MEN1 gene","volume":"4","author":"Hannan","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2025.02.001_bib150","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1530\/EJE-15-0691","article-title":"Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'\u00e9tude des Tumeurs Endocrines study","volume":"173","author":"Thevenon","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2025.02.001_bib151","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.surg.2020.04.067","article-title":"Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies","volume":"169","author":"Pieterman","year":"2021","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.eprac.2025.02.001_bib152","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/humu.23746","article-title":"Proposition of adjustments to the ACMG-AMP framework for the interpretation of MEN1 missense variants","volume":"40","author":"Romanet","year":"2019","journal-title":"Hum Mutat"},{"issue":"11","key":"10.1016\/j.eprac.2025.02.001_bib153","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0093","article-title":"Systematic detection of mosaicism by using digital NGS reveals three new MEN1 mosaicisms","volume":"11","author":"Lagarde","year":"2022","journal-title":"Endocr Connect"},{"issue":"7","key":"10.1016\/j.eprac.2025.02.001_bib154","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/PAS.0000000000002050","article-title":"Diagnostic utility of menin immunohistochemistry in patients with multiple endocrine neoplasia type 1 syndrome","volume":"47","author":"Verschuur","year":"2023","journal-title":"Am J Surg Pathol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25000382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25000382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:58:18Z","timestamp":1762549098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25000382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":155,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1530891X25000382"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.02.001","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Association of Clinical Endocrinology Consensus Statement on Management of Multiple Endocrine Neoplasia Type 1","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}